Scarr Elizabeth, Pavey Geoffrey, Copolov David, Dean Brian
The Rebecca L. Cooper Research Laboratories, The Mental Health Research Institute of Victoria, Australia.
Schizophr Res. 2004 Dec 1;71(2-3):383-92. doi: 10.1016/j.schres.2004.02.007.
There is strong evidence that hippocampal 5-hydroxytryptamine (5-HT) systems are affected in schizophrenia and hence we have studied a number of markers of the 5-HT system in hippocampi from subjects with schizophrenia. Using in situ radioligand binding with autoradiography we measured [(3)H]proplyamino-8-hydroxy-1,2,3,4-tetrahydronapthalene, [(3)H]ketanserin and [(3)H]sumatriptan binding in hippocampi from 20 schizophrenic and 20 control subjects. There were significant decreases in the density of [(3)H]ketanserin binding to the 5-HT(2A) receptor (5-HT(2A)R) in the Cornu Ammonis (CA) 3 (p=0.006), CA 1 (stratum radiatum p=0.02; pyramidal layer p=0.0008) and subiculum (pyramidal layer p=0.0004), as well as methiothepin-insensitive [(3)H]sumatriptan binding to the 5-HT(1F)R in the CA 1 (p=0.016), stratum radiatum/lacunosum moleculare (p=0.04) and subiculum (p=0.015) from subjects with schizophrenia. There were no differences in the densities of 5-HT(1A)R, 5-HT(1D)R or 5-HT(4)R in hippocampi from subjects with schizophrenia. These data support the hypothesis that regionally specific reductions in the density of the 5-HT(2A)R and 5-HT(1F)R are a component of the pathological processes underlying schizophrenia.
有强有力的证据表明,精神分裂症患者的海马5-羟色胺(5-HT)系统受到影响,因此我们研究了精神分裂症患者海马中5-HT系统的一些标志物。我们采用原位放射性配体结合放射自显影技术,测量了20例精神分裂症患者和20例对照者海马中[(3)H]丙胺基-8-羟基-1,2,3,4-四氢萘、[(3)H]酮色林和[(3)H]舒马曲坦的结合情况。[(3)H]酮色林与5-HT(2A)受体(5-HT(2A)R)结合的密度在海马角(CA)3(p = 0.006)、CA1(辐射层p = 0.02;锥体细胞层p = 0.0008)和下托(锥体细胞层p = 0.0004)显著降低,精神分裂症患者CA1(p = 0.016)、辐射层/分子层(p = 0.04)和下托(p = 0.015)中对甲硫哒嗪不敏感的[(3)H]舒马曲坦与5-HT(1F)R的结合也显著降低。精神分裂症患者海马中5-HT(1A)R、5-HT(1D)R或5-HT(4)R的密度没有差异。这些数据支持这样的假说,即5-HT(2A)R和5-HT(1F)R密度的区域特异性降低是精神分裂症潜在病理过程的一个组成部分。